Interventions for Tuberculosis Control and Elimination 2002
Interventions for Tuberculosis Control and Elimination 2002
Interventions for Tuberculosis Control and Elimination 2002
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
281. LeBel M, Masson E, Guilbert E, Colborn D, Pacquet F, Allard S, Vallée F,<br />
Narang PK. Effects of rifabutin <strong>and</strong> rifampicin on the pharmacokinetics of<br />
ethinylestradiol <strong>and</strong> norethindrone. J Clin Pharmacol 1998; 38: 1042-50.<br />
282. Udwadia ZW, Sridhar G, Beveridge CJ, Soutar C, McHardy GJR, Leitch AG.<br />
Catastrophic deterioration in asthma induced by rifampicin in steroid-dependent<br />
asthma. Respir Med 1993; 87: 629.<br />
283. Powell-Jackson PR, Gray BJ, Heaton RW, Costello JF, Williams R, English J.<br />
Adverse effect of rifampicin administration on steroid-dependent asthma.<br />
Rev Respir Dis 1983; 128: 307-10.<br />
Am<br />
284. Atkin SL, Masson EA, Bodmer CW, Walker BA, White MC. Increased insulin<br />
requirement in a patient with type 1 diabetes on rifampicin. (Correspondence).<br />
Diabetic Medicine 1993; 10: 392.<br />
285. Takasu N, Yamada T, Miura H, Sakamoto S, Korenaga M, Nakajima K,<br />
Kanayama M. Rifampicin-induced early phase hyperglycemia in humans. Am<br />
Rev Respir Dis 1982; 125: 23-7.<br />
286. Nolan SR, Self TH, Norwood JM. Interaction between rifampin <strong>and</strong> levothyroxine.<br />
Southern Med J 1999; 92: 529-31.<br />
287. Van Buren D, Wideman CA, Gibbons S, Van Buren CT, Jarowenko M, Flechner<br />
SM, Frazier OH, Cooley DA, Kahan BD. The antagonistic effect of rifampin<br />
upon cyclosporine bioavailability. Transplant Proc 1984; 16: 1642-5.<br />
288. Daniels NJ, Dover JS, Schachter RK. Interaction between cyclosporin <strong>and</strong><br />
rifampicin. (Correspondence). Lancet 1984; 2: 639.<br />
289. Coward RA, Raftery AT, Brown CB. Cyclosporin <strong>and</strong> antituberculous therapy.<br />
(Correspondence). Lancet 1985; 1: 1342-3.<br />
290. Freitag VL, Skifton RD, Lake KD. Effect of short-term rifampin on stable<br />
cyclosporine concentrations.<br />
871-2.<br />
(Correspondence). Ann Pharmacother 1999; 33:<br />
291. Kiuchi T, Tanaka K, Inomata Y, Uemoto S, Satomura K, Egawa H, Uyama S,<br />
Sano K, Okajima H, Yamaoka Y. Experience with tacrolimus-based immunosuppression<br />
in living-related liver transplantation complicated with graft tuberculosis:<br />
interaction with rifampicin <strong>and</strong> side effects.<br />
3171-2.<br />
Transplant Proc 1996; 28:<br />
292. Kreek MJ, Garfield JW, Gutjahr CL, Giusti LM. Rifampin-induced methadone<br />
withdrawal. N Engl J Med 1976; 294: 1104-6.<br />
293. Raistrick D, Hay A, Wolff K. Methadone maintenance <strong>and</strong> tuberculosis treatment.<br />
BMJ 1996; 313: 925-6.<br />
294. Schlatter J, Madras JL, Saulnier JL, Poujade F. Interactions médicamenteuses<br />
avec la méthadone. Presse Méd 1999; 28: 1381-4.<br />
295. Chouraqui JP, Bessard G, Favier M, Kolodie L, Rambaud P. Hémorrhagie par<br />
avitaminose K chez la femme enceinte et le nouveau-né.<br />
447-50.<br />
Thérapie 1982; 37:<br />
188